Notably, both breast and pancreatic cancers exhibited high mutation and copy number loss rates for ACVR1B. ACVR1B mRNA levels were significantly reduced in breast and pancreatic tumors compared to normal tissues (Fig. 1a, b). The gene discussed is ACVR1B; the disease is familial pancreatic carcinoma.